1. Home
  2. GAUZ vs CASI Comparison

GAUZ vs CASI Comparison

Compare GAUZ & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gauzy Ltd. Ordinary Shares

GAUZ

Gauzy Ltd. Ordinary Shares

HOLD

Current Price

$1.06

Market Cap

22.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo CASI Pharmaceuticals Inc.

CASI

CASI Pharmaceuticals Inc.

HOLD

Current Price

$1.00

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAUZ
CASI
Founded
2009
1991
Country
Israel
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
19.7M
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
GAUZ
CASI
Price
$1.06
$1.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.50
$4.00
AVG Volume (30 Days)
277.0K
48.6K
Earning Date
03-10-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$96,810,000.00
$26,846,000.00
Revenue This Year
$22.59
N/A
Revenue Next Year
$59.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.87
21.72
52 Week Low
$0.86
$0.75
52 Week High
$12.13
$3.09

Technical Indicators

Market Signals
Indicator
GAUZ
CASI
Relative Strength Index (RSI) 44.57 54.84
Support Level $0.86 $0.90
Resistance Level $1.88 $1.01
Average True Range (ATR) 0.19 0.10
MACD 0.09 0.01
Stochastic Oscillator 17.98 52.78

Price Performance

Historical Comparison
GAUZ
CASI

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: